"Patience is a Super Power" - "The Money is in the waiting"
Showing posts with label batteries. Show all posts
Showing posts with label batteries. Show all posts

Saturday, October 3, 2026

Kraken Robotics 60,000 Sq Ft Battery Plant is now operational

 


October 2026 — Update to our August 7, 2025 article

When we wrote our original article, “Kraken Robotics – NATO Navy supplier is moving up the ladder with massive, undersea battery facility!”, one of the most important pieces of our investment thesis was Kraken Robotics' planned 60,000-square-foot SeaPower™ battery manufacturing facility in Nova Scotia.

At the time, it was still a plan.

Today, it is becoming an operating asset — and Kraken Robotics itself has evolved into a considerably larger company.Kraken Robotics Update: The Battery Expansion We Were Waiting For

From Promise to Production

In August 2025, Kraken had committed approximately C$10 million to establish the Nova Scotia facility. Management expected it to substantially increase SeaPower battery manufacturing capacity and ultimately help bring total potential battery production toward C$200 million annually.

That expansion is no longer theoretical.

Kraken subsequently confirmed completion of the new Nova Scotia manufacturing facility, and in March 2026 CEO Greg Reid said battery manufacturing there was coming online.

The company's April investor presentation subsequently identified Halifax, Nova Scotia and Rostock, Germany as its battery manufacturing locations.

This gives Kraken something increasingly important in the rapidly expanding autonomous-underwater market:

Significant SeaPower battery manufacturing capability on both sides of the Atlantic.

And The Customers Are Arriving

Capacity means little without demand.

This is where the story becomes particularly interesting.

In January 2026, Kraken announced C$35 million in SeaPower battery sales to three customers.

In March, Kraken announced another approximately C$24 million of defence orders across SeaPower batteries, KATFISH and Kraken SAS.

In April, another C$28 million in SeaPower battery and SAS orders followed, involving five customers. Kraken said its technology was then integrated, or being integrated, into more than 30 different UUV platform types worldwide.

The company has therefore moved well beyond proving that SeaPower works.

It is increasingly about scaling production.

The XL-UUV Development May Be Even More Important

One development since our original article deserves particular attention.

Kraken has signed a long-term Master Supply Agreement with a major international conglomerate developing extra-large unmanned underwater vehicles — XL-UUVs.

The customer has not been publicly identified.

That means we should not speculate that it is any particular defence contractor.

But the size of these underwater vehicles helps explain why this opportunity matters.

Kraken's April 2026 investor material indicated that an XL-UUV can contain approximately 50–60 of its 20-kWh SeaPower battery modules.

That changes the economics considerably.

A future in which large autonomous submarines are produced in meaningful numbers could require substantially more battery capacity than today's smaller UUV market.

And Kraken has been building the manufacturing infrastructure to participate in exactly that market.

A Better Battery Opens Another Market

Kraken has also introduced a more compact SeaPower architecture offering approximately a 30% improvement in energy density.

That is strategically important because SeaPower is no longer aimed principally at very large underwater vehicles.

The new architecture allows Kraken to address small and medium-sized UUVs as well.

Kraken therefore potentially participates across much of the autonomous underwater spectrum:

Small UUV → Medium UUV → Large UUV → XL-UUV

For an investor, this may ultimately be more important than any single battery contract.

Kraken is attempting to become an enabling technology supplier to the broader underwater-autonomy industry.

Kraken Is No Longer The Company We Wrote About In August 2025

There has been another major change.

Kraken completed its acquisition of Covelya Group in July 2026.

That brought businesses including Sonardyne, EIVA, Voyis, Wavefront Systems and others into the organization.

Kraken's technology portfolio now spans much more of the underwater stack:

CapabilityKraken/Covelya exposure
Subsea powerSeaPower batteries
Synthetic Aperture SonarKraken SAS
Mine huntingKATFISH
Underwater navigationSonardyne
Acoustic positioning & communicationsSonardyne
Mission/survey softwareEIVA
Optical subsea imagingVoyis
Intruder detection & forward-looking sonarWavefront
Subsea services/LiDAR3D at Depth

This is a very different company from the relatively specialized Canadian ocean-technology business we originally followed.

The Numbers Are Scaling Too

Kraken reported C$102.2 million of revenue and C$25.0 million of Adjusted EBITDA for 2025.

Following the Covelya acquisition, management's 2026 guidance increased dramatically.

Kraken currently expects:

Revenue: C$290–C$320 million

Adjusted EBITDA: C$65–C$75 million

Adjusted EBITDA margin: approximately 22%–23%

Perhaps even more significant, by the end of Q2 Kraken and Covelya had announced approximately C$355 million of combined 2026 orders.

This does not mean C$355 million automatically becomes 2026 revenue. Order timing and revenue recognition matter.

But it demonstrates the scale of the opportunity now confronting the company.

Why The Nova Scotia Plant Matters More Today Than It Did In 2025

When we first wrote about the plant, we viewed it primarily as a capacity expansion.

Today we see it somewhat differently.

It is potentially a strategic piece of North American allied-defence manufacturing infrastructure.

Kraken can manufacture subsea batteries in Canada while maintaining its European battery operation in Germany.

That provides geographic diversification and puts production closer to North American customers at precisely the time when autonomous maritime systems are becoming increasingly important to Western defence planning.

And the plant includes multiple pressure-testing tanks rated to 6,000 metres.

This is specialized infrastructure, not a conventional battery assembly operation.

Our Investment Thesis Has Evolved

Our original thesis was relatively simple:

Kraken possessed excellent subsea sonar and battery technology and was positioned to benefit from growing NATO and commercial demand for autonomous underwater systems.

We believe the thesis has broadened considerably.

Kraken is increasingly becoming a subsea technology platform supplying many of the technologies required to make autonomous underwater systems work:

POWER → NAVIGATION → COMMUNICATION → SONAR → IMAGING → SOFTWARE → DATA

The Nova Scotia SeaPower facility fills an especially important part of that stack: power and endurance.

Without sufficient energy storage, an autonomous underwater vehicle cannot stay underwater longer, travel farther or carry increasingly sophisticated sensor payloads.

That makes battery technology a potentially valuable technological chokepoint.

What We Are Watching Now

The next question is no longer:

“Will Kraken build the Nova Scotia battery plant?”

It has.

The questions for shareholders now become:

How quickly will production ramp?

How much of the potential C$200 million annual battery capacity can Kraken utilize?

Will the XL-UUV supply agreement turn into large recurring production orders?

How quickly will new small- and medium-UUV customers adopt the higher-density SeaPower architecture?

And finally:

Can Kraken successfully integrate Covelya while maintaining the growth and margins investors now expect?

Those are the metrics that should increasingly determine the investment case through 2027 and 2028.

Investment Perspective — October 2026

Our August 2025 article described a promising Canadian defence-technology company investing aggressively ahead of anticipated demand.

Fourteen months later, several pieces of that thesis have materially advanced.

The Nova Scotia battery plant has been completed.

SeaPower orders have increased.

Kraken has gained additional defence customers.

Its technology is being integrated across more than 30 UUV platform types.

A long-term battery agreement has been signed with a manufacturer developing XL-UUVs.

And the Covelya acquisition has transformed Kraken into a substantially larger international subsea-technology company.

There are still important risks: Covelya integration, execution, working-capital requirements, contract timing, defence procurement delays and the challenge of filling newly installed manufacturing capacity.

But there is an important distinction between the Kraken story of August 2025 and the Kraken story today:

In 2025, investors were largely buying the expectation of scale.

In late 2026, we are beginning to see that scale being built and commercialized.

Ed Note

We originally added to our PNG position on August 7, 2025 because we believed Kraken was sitting at the intersection of several long-duration trends: NATO naval modernization, autonomous underwater vehicles, mine warfare, subsea infrastructure protection and offshore energy.

The opening of the Nova Scotia SeaPower manufacturing operation strengthens that thesis.

In our view, the next major milestone is not another factory announcement.

It is utilization.

If Kraken can progressively fill this new battery capacity with recurring UUV and particularly XL-UUV production orders, the Nova Scotia facility could become one of the more important growth assets inside the expanded Kraken organization.

That is what we will be watching closely through 2027.

Further: the connections between the new German made subs being stationed in Halifax NS with Canada's East Coast Navy, the German battery manufacturing plant, The idea that these subs will eventually be "command platforms" for XLUUV clusters, and the fact that the Arctic is a major concern of CAF cannot be ignored either. 

Currently there is no factual evidence for these connections however, I have learned over many years that,  "If it walks like a duck, swims like a duck and quacks like a duck, It's probably a duck!

We've been busy adding to our position!

Previous Articles:

Kraken Robotics in a great position to help supply NATO navies with their sub sea technology!


Saturday, October 11, 2025

Lithium is the new oil AND, Smackover is America's new wellhead!

 


⚡ Investment Report: Smackover Lithium Project

Joint Venture between Standard Lithium Ltd. (NYSE: SLI / TSX-V: SLI) and Equinor ASA (NYSE: EQNR)


🧭 Executive Summary

As America and China continue to lock horns over critical minerals and strategic materials, smaller North American players — Standard Lithium (SLI), Critical Metals Corp (CRML), Ucore Rare Metals (UCU), MP Materials (MP), and Avalon Advanced Materials (AVL) — are poised to thrive. These companies control valuable deposits of lithium, rare earths, and other critical minerals that underpin the global energy transition.

Among them, the Smackover Lithium Project stands out as one of the most strategically positioned and technically advanced lithium ventures in North America. With Standard Lithium as operator and Equinor ASA as a 45% partner, this project is well‑funded, technologically mature, and fully aligned with U.S. energy independence and clean‑tech industrial policy goals.


🌍 Geological & Strategic Context

🔹 The Smackover Formation

  • A geological giant stretching across the Gulf Coast Basin, running through southern Arkansas and eastern Texas.

  • Formed by porous carbonate rock layers that host brine rich in lithium and other dissolved minerals.

  • Already home to a mature industrial brine extraction ecosystem, historically focused on bromine production — creating ideal infrastructure for lithium development.

🔹 Project Zones

  • Southwest Arkansas (SWA) Project: Core area of lithium concentration with average 437 mg/L lithium; planned capacity of 30,000 tonnes/year battery‑grade LiOH.

  • East Texas Project: Expanding zone where brine samples have shown up to 806 mg/L lithium concentrations.

  • Both project areas are contiguous within the subsurface Smackover geological system, forming a unified development corridor.


⚙️ Technology & Operations

Direct Lithium Extraction (DLE)

  • Proprietary process developed by Standard Lithium; continuously operated pilot plant in El Dorado, AR since 2020.

  • >99% lithium recovery demonstrated, with minimal land and water use compared to evaporation ponds.

  • Produces high‑purity lithium hydroxide suitable for EV batteries.

  • Significantly shorter production cycles and lower carbon footprint.


🤝 Joint Venture Structure — "Smackover Lithium"

PartnerRoleOwnership
Standard Lithium (SLI)Project operator, technology owner55%
Equinor ASA (EQNR)Strategic investor, subsurface & capital partner45%
  • Equinor committed:

    • $30M upfront payment

    • $60M development work program

    • Up to $70M in milestone-based performance payments

  • DOE Grant: $225M awarded (January 2025) for Phase 1 SWA construction.

  • Operating JV name: Smackover Lithium — a separate entity governed jointly, designed to scale projects across the Smackover Basin.


💰 Financial and Partner Strength

Standard Lithium Ltd. (SLI)

  • Cash reserves: $31.2M (Dec 2024)

  • Debt: None

  • 100% operator of Smackover Lithium JV assets

  • Positioned as one of the few pure‑play U.S. lithium developers

Equinor ASA (EQNR)

  • Market Cap: ~$90B

  • P/E: 7.8×

  • P/S (TTM): 0.6

  • P/CF (TTM): 3.6×

  • Operating Margin: 28.4%

  • Dividend Yield: 8.4%

  • Strategic energy supermajor from Norway with deep pockets and global project execution capacity.

  • Expanding beyond hydrocarbons into low‑carbon, critical‑minerals, and hydrogen sectors.

“Energy – Europe – America – Equinor ASA. P/E 7.8x, Dividend 8.4% — Nuff Said.”


🧱 Development Roadmap

MilestoneTimelineStatus
JV Formation with EquinorQ1 2025✅ Completed
DOE $225M Grant SecuredQ1 2025✅ Completed
FEED & Engineering StudiesQ2–Q3 2025🔄 In Progress
Construction Start (SWA Phase 1)Late 2025 – Early 2026🔜 Planned
East Texas Resource Expansion2025–2026🔄 Active
Commercial Production Launch2027 (est.)🕒 Target

📈 Investment Thesis

  1. Strategic Resource Control: SLI and Equinor control one of North America’s richest lithium brine systems.

  2. Government Support: DOE grant validates technical and geopolitical importance.

  3. Technology Edge: Proven DLE technology de‑risks extraction and accelerates scalability.

  4. Institutional Partner: Equinor’s financial strength ensures long‑term project execution.

  5. Critical Mineral Supercycle: Geopolitical friction between the U.S. and China will continue to amplify the value of domestic lithium production.

We are long both SLI and EQNR. The combination of technology, capital, and national priority creates a unique, asymmetric upside in the North American lithium sector.


⚠️ Risks & Mitigations

RiskImpactMitigation
DLE Scale-Up RiskTechnical challenge in commercial scalingMulti‑year pilot proven, DOE oversight ensures compliance
Permitting/RegulatoryPotential local or state delaysFavorable Arkansas regulatory climate; existing brine infrastructure
Lithium Price VolatilityMarket-driven revenue swingsU.S. IRA incentives, potential offtake contracts, DOE-supported floor pricing
CapEx InflationRising material costsEquinor funding cushions; DOE grant offsets 20–30% of initial capex

🌎 Macro Context: The Critical Mineral Rivalry

The U.S.–China rivalry over energy transition materials has escalated into a strategic resource race. Lithium, nickel, and rare earths have emerged as the new oil — essential to EVs, grid storage, and defense applications.

Small-cap developers like SLI, CRML, UCU, MP, and AVL occupy a unique sweet spot:

  • They own the feedstock of the next industrial era.

  • They are becoming acquisition targets for major energy and materials firms (e.g., Equinor, ExxonMobil, Rio Tinto).

  • They provide investors with exposure to critical mineral leverage without megacap dilution.


🧩 Conclusion

The Smackover Lithium Project is more than a single asset — it is a strategic partnership between innovation (SLI) and institutional power (Equinor), underpinned by U.S. government backing.

With world-class geology, proven technology, strong partners, and policy tailwinds, Smackover Lithium is positioned to become a cornerstone of America’s clean energy supply chain.

→ In short:

Lithium is the new oil. Smackover is America’s wellhead.



Tuesday, February 4, 2025

Takeover Targets: As 2025 rolls out and acquisitions begin to take hold, we list (speculatively) 12 possibilities of acquisitions in the Tech and Healthcare sector!


 Below is a high‐level informational look at potential suitability as a takeover/acquisition targets, along with a very rough ranking from “most likely” down to “least likely.” Obviously, no one (outside of insider circles) can say for sure which deals will happen; M&A activity depends on broader market conditions, valuation swings, regulatory climate, and the acquiring company’s strategy. Think of this as a conversation starter, not financial advice.


1. CHPT (ChargePoint)

Sector: EV Charging Infrastructure

Why it could be acquired:

  • One of the largest independent EV charging plays in North America, with a recognizable brand and fairly extensive charging footprint.
  • Strategic fit for an energy major (e.g., BP, Shell) or a large automaker aiming to own more of the EV ecosystem.
  • EV charging is a fragmented space with many smaller players; consolidation is inevitable as the market matures.

Potential roadblocks:

  • Valuations in the EV/clean tech sector can be volatile and may deter acquirers if the price is too high.
  • Some large corporations may opt to build their own charging networks instead of buying.

Still, ChargePoint stands out as one of the more “obvious” names if a big fish wants immediate scale in EV charging at a bargain basement price!


2. ENVX (Enovix)

Sector: Next‐Gen Battery Technology

Why it could be acquired:

  • Innovative silicon‐anode battery design promising higher energy density and better safety.
  • Potential synergy for consumer electronics giants (Samsung, Apple), EV OEMs, or battery incumbents (Panasonic, LG, CATL) looking for a technological leap.
  • Battery tech is notoriously difficult—an acquirer might see value in simply scooping up Enovix’s IP and manufacturing processes rather than starting from scratch.

Potential roadblocks:

  • Must demonstrate a clear path to mass production; sometimes advanced battery startups stall if they can’t scale.
  • If the technology proves out, Enovix may want to remain independent until valuation is higher.

Given the wave of EV/battery investments worldwide, Enovix is a prime candidate for a strategic purchase.


3. IONQ (IonQ)

Sector: Quantum Computing

Why it could be acquired:

  • IonQ is widely viewed as a leader in trapped‐ion quantum computing, which (so far) has shown significant promise for scalability and error reduction.
  • Big Tech (Google, Microsoft, Amazon, IBM) have quantum ambitions and might prefer to acquire proven teams and IP rather than build everything in‐house.
  • Corporate interest in quantum is growing, and the sector remains fairly small, which makes M&A more feasible.

Potential roadblocks:

  • IonQ’s partnerships with various cloud providers might complicate a takeover by one specific hyperscaler.
  • The company could also choose to remain independent while quantum valuations continue to climb.

Still, among public quantum players, IonQ is often cited as the top near‐term takeover possibility.


4. PATH (UiPath)

Sector: Robotic Process Automation (RPA)

Why it could be acquired:

  • UiPath is a leader in RPA software, a segment central to enterprise digital transformation and hyperautomation.
  • Large enterprise software vendors (e.g., Microsoft, SAP, Salesforce, Oracle) all have some automation offerings. Acquiring a dominant RPA platform could solidify market share.
  • UiPath’s stock and valuation took some hits in prior years, making it more approachable from an M&A perspective.

Potential roadblocks:

  • UiPath still has substantial market share and cash, and it may see itself as a platform play with runway for independent growth.
  • Tech giants may continue improving their in‐house automation (e.g., Microsoft with Power Automate).

Overall, UiPath is one of the more established, brand‐name midcaps in enterprise software—very plausible as an acquisition target.


5. EDIT (Editas Medicine)

Sector: Gene Editing (CRISPR)

Why it could be acquired:

  • Editas is one of the earliest CRISPR/Cas9 gene‐editing platform companies.
  • Big pharma and large biotech are always on the lookout for next‐gen therapeutic platforms, especially gene editing.
  • If Editas shows promising clinical data in areas with high unmet need, an acquisition could be straightforward.

Potential roadblocks:

  • Competition in gene editing is fierce (CRSP, NTLA, BEAM, Prime, etc.). Acquirers might wait to see definitive clinical proof before pulling the trigger.
  • Current biotech valuations fluctuate with trial data and FDA updates; the timing of a deal can be tricky.

Nonetheless, Editas sits in that sweet spot—recognizable IP, possible proof‐of‐concept data, and not too large for a big pharma to swallow.


6. BEAM (Beam Therapeutics)

Sector: Gene Editing (Base Editing)

Why it could be acquired:

  • Pioneered base‐editing technology, a potentially more precise and versatile approach than traditional CRISPR/Cas9.
  • If Beam’s pipeline matures or shows strong clinical data, large pharma could move in.
  • The entire gene‐editing field is ripe for consolidation as these technologies inch closer to commercial reality.

Potential roadblocks:

  • As with Editas, valuations depend heavily on clinical milestones; large swings in the share price can disrupt M&A dealmaking.
  • Base editing might still be considered “early stage,” so risk‐averse acquirers might wait.

If big pharma wants to corner advanced gene editing, Beam is near the top of the conversation.


7. DNA (Ginkgo Bioworks)

Sector: Synthetic Biology / Bioengineering

Why it could be acquired:

  • Ginkgo has a large “organism engineering” platform and a broad base of corporate partnerships in pharma, agriculture, and industrial biotech.
  • Synthetic biology is attracting interest as companies look to produce chemicals, pharmaceuticals, and materials more sustainably.
  • A conglomerate or large pharma might acquire Ginkgo for its established foundry and IP.

Potential roadblocks:

  • Ginkgo is fairly high profile and has historically commanded a hefty valuation, which can scare away suitors.
  • Its model (partnering across many domains) might be more valuable to remain standalone rather than fold into a single large parent.

Despite that, Ginkgo consistently comes up in speculation about platform biotech acquisitions, especially if valuations become more attractive.


8. AEVA (Aeva Technologies)

Sector: LiDAR / Sensing for Autonomous Vehicles

Why it could be acquired:

  • Specialized FMCW (frequency modulated continuous wave) LiDAR technology that claims long‐range performance.
  • Automakers and Tier 1 suppliers are consolidating the LiDAR landscape to secure next‐gen sensing IP.
  • While LiDAR market hype has cooled, it’s still strategic tech for ADAS/autonomy, and bigger players may want to snap up promising smaller teams.

Potential roadblocks:

  • Fierce competition (Velodyne/Ouster, Luminar, Innoviz, etc.), all vying for design wins in a market that remains uncertain.
  • Large OEMs sometimes favor multiple LiDAR suppliers or in‐house solutions, reducing the impetus to buy outright.

Given the wave of LiDAR M&A, Aeva is squarely in the conversation—especially if it can prove superior sensor performance.


9. VKTX (Viking Therapeutics)

Sector: Biotech (metabolic and endocrine disorders)

Why it could be acquired:

  • Viking focuses on metabolic diseases (NASH, obesity, etc.)—areas where big pharma has spent billions acquiring late/pre‐clinical assets.
  • If Viking posts strong results in key trials, it could attract interest as a complement to established metabolic portfolios.

Potential roadblocks:

  • Clinical risk is high, and some metabolic markets (like NASH) are littered with failed trials.
  • The company’s pipeline needs to stand out vs. competition from Madrigal, Intercept, etc.

Still, Viking is a prime candidate for a typical biotech “pipeline buy” scenario if data is compelling. 

(Q: What do Piper Sandler, Raymond James and Wainwright's analysts know that you don't know? Viking is trading today at $32 and they have a combined price target over $100 as recently as Feb 6th!)


10. CABA (Cabaletta Bio)

Sector: Biotech (cell therapy for autoimmune diseases)

Why it could be acquired:

  • Targeting B‐cell mediated autoimmune disorders with engineered T cells, a hot therapeutic area.
  • Smaller market cap relative to some cell therapy peers—makes it more digestible for a larger biotech or pharma.

Potential roadblocks:

  • Preclinical/early‐stage therapies can remain speculative; big acquirers often wait for proof‐of‐concept data.
  • Competition from other next‐gen autoimmune therapies, including gene editing approaches.

If Cabaletta can show strong early data, it could be a logical bolt‐on for a big immunology player.


11. QBTS (D‐Wave Quantum Inc.)

(Assuming “QBTS” is indeed D‐Wave; they re‐listed on the NYSE under “QBTS.”)

Sector: Quantum Computing (annealing‐based + gate‐model in development)

Why it could be acquired:

  • D‐Wave has longstanding expertise in quantum annealing, which is somewhat unique compared to gate‐based approaches (IonQ, Rigetti, etc.).
  • They hold valuable quantum IP and have partnerships with Fortune 500 companies exploring early quantum use cases.

Potential roadblocks:

  • D‐Wave’s annealing technology, while proven for certain optimization problems, is less generalizable than gate‐based quantum.
  • Larger tech players might see IonQ, PsiQuantum, or others as more future‐proof for universal quantum computing.

A takeover could happen, but D‐Wave may be overshadowed by gate‐based quantum leaders unless an acquirer has a specific interest in annealing.


12. MYNA (Mynaric)

Sector: Laser Communications for Aerospace

Why it could be acquired:

  • Specializes in optical communications terminals for airborne and space‐based platforms—an increasingly important technology for satellite constellations, UAVs, and secure comms.
  • Could be strategic for a defense contractor (Lockheed, Northrop Grumman) or a space/cellular network operator looking to integrate proprietary laser links.

Potential roadblocks:

  • Military/space contracts can be very lumpy and long‐cycle. Acquirers might wait to see major contract wins or proof of revenue scale.
  • Other laser comms startups exist; the field is still somewhat emerging.

If the sector consolidates or a prime defense contractor wants to lock in that IP, Mynaric is definitely a candidate, but less “top of mind” than more mainstream tech.


13. APLD (Applied Digital)

Sector: High‐Performance Computing / Data Center Services

Why it could be acquired:

  • Offers specialized data center hosting (sometimes aimed at crypto mining or HPC/AI infrastructure).
  • As data centers consolidate, a larger cloud or HPC player might pick up smaller operators—especially if they have strategic locations or cheap power.

Potential roadblocks:

  • The HPC/data center market is dominated by hyperscalers (AWS, Azure, Google Cloud) who typically build out their own capacity rather than buy smaller operators.
  • If much of APLD’s revenue is tied to crypto mining, that niche has been volatile; some acquirers may see more risk than reward.

An acquisition isn’t out of the question, but Applied Digital is probably lower on the “imminent M&A” list relative to more mainstream tech or biotech names.


Putting It All Together: A Possible Ranking

Everyone’s criteria differ, but if forced to line these up from “most likely” to “least likely” (in terms of near‐ to mid‐term M&A buzz), here’s a sample ordering:

  1. CHPT (ChargePoint) – High EV infra consolidation interest
  2. ENVX (Enovix) – Next‐gen battery tech is a key M&A theme
  3. IONQ (IonQ) – Leader in quantum, prime for a big-tech grab
  4. PATH (UiPath) – RPA market leader, fits enterprise software giants
  5. EDIT (Editas) – CRISPR pioneer, plausible buy for big pharma
  6. BEAM (Beam Therapeutics) – Base-editing leader, also a strong biotech target
  7. DNA (Ginkgo Bioworks) – Synthetic bio platform, albeit large and pricier
  8. AEVA (Aeva) – LiDAR, a consolidation play in automotive sensors
  9. VKTX (Viking) – Promising metabolic pipeline, a classic biotech buy scenario
  10. CABA (Cabaletta) – Early-stage autoimmune cell therapy, smaller but appealing
  11. QBTS (D‐Wave) – Unique quantum approach; overshadowed by gate‐based players
  12. MYNA (Mynaric) – Laser comms for aerospace/defense; niche but possible
  13. APLD (Applied Digital) – HPC/crypto hosting; plausible but less top-of-radar

Again, the above is inherently speculative. Biotech M&A can happen very fast if clinical data shines (which might catapult something like VKTX or CABA up the list). Meanwhile, quantum deals could accelerate if a big platform player decides it’s time to “buy rather than build.” And of course, macro conditions—interest rates, regulatory climate, or shifts in capital availability—can greatly impact who acquires whom, and when.


Disclaimer

This overview is for general information only. It is not financial or investment advice, and it is not a guarantee that any acquisition will occur. Always do your own due diligence or consult a licensed financial professional before making investment decisions.

Chargepoint is trading today as a pennystock! It would not be a surprise if a major energy company acquired CHP in 2025!


Tuesday, January 14, 2025

Enovix knows full well that a world of EVs, Automation, Robotics and energy storage, will require millions of batteries!

ENVX battery manufacturing plants

Enovix is ramping up production of it's new batteries, hiring top experts and hinting at a possible partnership with Apple!

 
Enovix Corp (ENVX) – Updated Business Report (January 2025)


1. Introduction

Enovix Corporation (NASDAQ: ENVX) has continued to garner attention in the energy storage sector with its disruptive 3D silicon-anode lithium-ion battery architecture. Since its public listing in 2021 and subsequent production milestones reached in 2023 and 2024, Enovix has moved aggressively toward commercializing its unique battery design for consumer electronics, electric vehicles (EVs), and, increasingly, robotics applications. This report incorporates the most recent updates on Enovix’s technology developments, manufacturing capacity expansions, and potential collaborations with major companies—particularly Apple—while evaluating the broader outlook for Enovix’s role in a rapidly electrifying world.


2. Recent Technology and Product Advancements

  1. 3D Silicon-Anode Architecture


    • Enovix’s core innovation remains its patented 3D architecture, which integrates a 100% active silicon anode. This design reportedly provides up to 30–40% higher energy density compared to standard lithium-ion batteries using graphite anodes.
    • Ongoing research since late 2023 focuses on enhancing cycle life and fast-charging capabilities. Recent internal testing shows improvements in maintaining high capacity retention over extended charge-discharge cycles—crucial for consumer electronics and potential EV applications.


  2. Advanced Safety and Thermal Management

    • Enovix continues to emphasize safety features, including containment structures designed to mitigate thermal runaway.
    • Improved thermal management has positioned Enovix as a contender in applications where battery integrity under stress (e.g., drones, robotics, automotive) is paramount.
  3. Fast-Charging Improvements

                                           Enovix boasts EV fast charging in 10 minutes!

    • As of Q4 2024, Enovix claims faster charge rates without sacrificing battery life. This is especially relevant for smartphones, wearable devices, and other consumer electronics where fast recharging is a key competitive advantage.



3. Manufacturing and Production Expansion

  1. Fab-1 (Fremont, California)

    • Enovix’s first manufacturing line in Fremont has transitioned from pilot-scale to low-volume commercial production. Yield rates have gradually increased due to process refinements and equipment upgrades throughout 2024.
    • Recent guidance indicates that Fremont’s facility throughput has reached steady-state operations, paving the way for higher-volume output in 2025.
    • Fab-2 (Global Expansion Plans)
    • Enovix new “Fab-2” manufacturing plant, is being constructed at this writing in Penang, Malaysia, selected for supply-chain advantages and proximity to major consumer electronics manufacturers, with a target to begin pilot production in 2026.
  2. Automation and Process Innovations


    • The company continues to invest heavily in manufacturing automation, aiming to reduce defect rates and streamline operations. This push is critical for bringing down costs and meeting large-scale consumer electronics demands.

4. Potential Partnerships and Client Landscape

  1. Apple


    • Rumored Collaboration: Market analysts and media outlets have repeatedly speculated on Apple’s interest in Enovix’s next-generation batteries to power future devices—particularly iPhones, iPads, and possibly the rumored AR/VR headsets.
    • Technological Fit: Apple’s emphasis on device battery life, fast charging, and safety aligns closely with Enovix’s product value proposition.
    • Probability of Partnership: While no formal agreement has been announced, multiple industry sources suggest that Apple has evaluated or is in the process of evaluating Enovix battery samples. 
    • The probability of a multi-year supply agreement remains speculative but is generally viewed as credible given Apple’s tendency to source cutting-edge battery technology for its flagship devices. If a deal materializes, it could significantly boost Enovix’s revenue and market credibility.
  2. Other Consumer Electronics OEMs

    • Enovix has sampled batteries to several Tier-1 and Tier-2 consumer electronics manufacturers in Asia. Initial feedback and pilot tests have reportedly been positive.
    • Partnerships could extend beyond smartphones to wearable devices, laptops, and other portable electronics where high energy density and safety are critical.
  3. Emerging EV and Robotics Segments


    • While consumer electronics remains the near-term commercial priority, Enovix is also in preliminary discussions with automotive Tier-1 suppliers to explore potential adoption in electric vehicles (especially for specialized packs or range extenders).

    • Robotics and drone manufacturers have also expressed interest in Enovix’s high energy density batteries. The improved power-to-weight ratio is particularly attractive for autonomous systems, aerial drones, and industrial robots.

5. Financial Health and Recent Performance

  1. Revenue Trajectory

    • Early sales from pilot-scale production and sample shipments contributed to modest revenues in 2023. According to Q3/Q4 2024 disclosures, revenues have begun to accelerate as the company onboards additional customers for low-volume orders.
    • The bulk of revenue growth is still anticipated from major supply agreements, pending successful qualification with top-tier OEMs.
  2. Capital Expenditure and Funding

    • Enovix secured additional funding in early 2024 through a combination of equity offerings and strategic investments. This infusion supports ramp-up expenses for Fab-1 and the initial groundwork for Fab-2.
    • The company’s balance sheet remains relatively strong, with cash reserves earmarked for scaling production and further R&D.
  3. Stock Performance

    • ENVX has experienced volatility, reflecting broader market swings in the tech and EV/battery sectors. Positive announcements about pilot trials or large-scale supply contracts often catalyze stock price gains.
    • Analysts generally maintain a cautiously optimistic outlook, citing Enovix’s unique technology advantage but also acknowledging the execution risks common to capital-intensive hardware startups.

6. Outlook in a World of EVs, Robotics, and Beyond

  1. Consumer Electronics Dominance

    • The most immediate commercial success for Enovix is likely in smartphones, laptops, wearable devices, and other portable gadgets that benefit from lighter, longer-lasting batteries.
    • If Apple—or another major OEM—signs a large-scale supply contract, Enovix’s technology could quickly become a market reference point for high-energy, safe batteries.
  2. Growing EV Opportunities

    • EVs represent a massive market opportunity. Though Enovix’s initial focus has been consumer electronics, improvements in silicon anode longevity and scale-up manufacturing could position the company to address specialized EV battery applications.
    • Partnerships or joint ventures with established automotive suppliers may help Enovix navigate the complexity and certification requirements of the automotive industry.
  3. Robotics, Drones, and Industrial Applications

    • The increasing electrification of robotics (both commercial and industrial) presents another long-term growth avenue. High energy density and robust safety features are major selling points for powering autonomous systems.
    • Drone manufacturers, in particular, require high power-to-weight ratios for longer flight times—an area where Enovix’s technology excels.
  4. Competitive and Regulatory Landscape

    • Other battery startups and established players (e.g., QuantumScape, Solid Power, LG Energy Solution, Samsung SDI) are investing heavily in next-gen battery solutions, including solid-state technology.
    • Regulatory push for greener energy solutions, along with government incentives for battery manufacturing, could bolster Enovix’s expansion plans. However, it also intensifies competition as more players vie for subsidies and market share.

7. Key Risks and Considerations

  1. Manufacturing Scale-up Risks
    • Transitioning from pilot to mass production remains a significant operational challenge. Any delay or yield issue could push back deliveries and affect financial performance.
  2. Supply Chain and Material Constraints
    • Silicon-based anodes require specialized materials and process controls. Global disruptions or shortages of critical materials could impact cost and production schedules.
  3. Customer Adoption Timelines
    • Large OEMs often have lengthy qualification and testing cycles. Even if Enovix’s technology is promising, converting pilot evaluations to full commercial contracts can take several product cycles.
  4. Competitive Pressure
    • The battery sector is highly competitive, with numerous companies pursuing advanced lithium-ion or solid-state solutions. Enovix must maintain technology and cost advantages to stand out.

8. Conclusion

Enovix stands at the forefront of next-generation lithium-ion battery technology, with its 3D silicon-anode architecture showing strong potential to reshape the landscape of consumer electronics, EVs, and robotics. The company’s manufacturing ramp in Fremont and planned global expansion signal that it is transitioning from technology innovator to commercial player.

Why It May Be a Good Investment in Early 2025:



With Fab-1 now producing commercial volumes and Fab-2 in the pipeline, Enovix is positioned to capitalize on growing demand for higher energy density batteries. Ongoing talks with major OEMs (including the possibility of a high-profile partnership with Apple), continued market interest in EV and robotics solutions, and a strong balance sheet provide a compelling growth story. While there are always risks in scaling and delivering at high volume, Enovix’s unique technology advantage in a rapidly expanding market suggests that the company could deliver outsized returns to early shareholders in 2025 and beyond.

Should Enovix execute effectively, it could emerge as a leading supplier of advanced lithium-ion batteries, shaping the next generation of consumer devices, electric vehicles, and robotic applications worldwide.


Disclaimer:
This report is based on publicly available information and industry insights as of January 2025. It is provided for informational purposes and should not be construed as financial or investment advice. Prospective investors and stakeholders are encouraged to conduct their own due diligence and consult professional advisors before making any decisions related to Enovix Corporation.

Related Articles:

Enovix is ramping up production of it's new batteries, hiring top experts and hinting at a possible partnership with Apple!

Friday, September 13, 2024

Enovix Corp holds over 130 issued patents, covering various aspects of their innovative battery technology.


Enovix Corporation has developed innovative lithium-ion battery technology, particularly focusing on their proprietary 3D Silicon™ Lithium-ion Battery architecture. The company's technology aims to offer higher energy density, improved performance, and faster charging times compared to traditional lithium-ion batteries.

These patents span areas such as battery architecture, manufacturing processes, and material science, which are key to their development of next-generation lithium-ion batteries.



Robustness of Enovix's Patent Portfolio

1. Extensive Patent Filings:

  • Proprietary Technology Protection: Enovix has filed numerous patents to protect its unique battery architecture and manufacturing processes. While I don't have the exact number of patents and applications, the company has emphasized building a strong intellectual property (IP) portfolio as a core part of its business strategy.

  • Global Coverage: The patents are filed not only in the United States but also in other key markets to ensure broad protection of their technology.

2. Key Areas of Patented Innovations:

  • 3D Cell Architecture:

    • Unique Design: Patents cover their innovative 3D cell architecture that increases energy density by stacking electrodes in a three-dimensional configuration.
    • Improved Performance: This design allows for more active material within the same battery volume, enhancing capacity without increasing size.
  • Silicon Anode Technology:

    • High Energy Density: Patents related to the use of silicon in the anode, which offers significantly higher capacity than traditional graphite anodes.
    • Durability Solutions: Innovations addressing the expansion issues of silicon during charging and discharging cycles, improving battery lifespan.
  • Manufacturing Processes:

    • Precision Engineering: Patents on proprietary manufacturing techniques that enable the production of their advanced battery designs at scale.
    • Cost Efficiency: Innovations that reduce production costs, making their technology more competitive in the market.

3. Competitive Edge Provided by Patents:

  • Barrier to Entry:

    • Protection from Competitors: A robust patent portfolio deters competitors from replicating Enovix's technology, preserving their market advantage.
    • Market Exclusivity: Enables Enovix to capitalize on their innovations without immediate competition in identical technologies.
  • Licensing Opportunities:

    • Revenue Streams: Patents allow Enovix to license their technology to other companies, creating additional income.
    • Strategic Partnerships: Intellectual property can be leveraged to form alliances with manufacturers and suppliers.
  • Investor Confidence:

    • Attracting Investment: A strong IP portfolio signals to investors that the company has valuable, protected assets, potentially leading to increased funding.
    • Market Valuation: Patents contribute to the overall valuation of the company, which can positively affect stock performance.

Conclusion

Enovix appears to have a robust portfolio of patents and patent applications, which likely gives it a competitive edge in the advanced battery market. The company's focus on protecting its technological innovations through patents can:

  • Secure Market Position: Prevent competitors from easily copying their technology.
  • Enhance Profitability: Allow for premium pricing and licensing deals.
  • Drive Growth: Support expansion into new markets and applications.

Recommendations for Further Information

To obtain the most current and detailed information about Enovix's patent portfolio:

  • Company's Investor Relations:

  • Patent Databases:

    • Search the United States Patent and Trademark Office (USPTO) database using "Enovix" as the assignee name to find published patents and applications.
    • Use international patent databases like the World Intellectual Property Organization (WIPO) for global filings.
  • Financial Reports:

    • Review Enovix's filings with the Securities and Exchange Commission (SEC), such as Form 10-K or 10-Q, where they typically discuss their intellectual property strategy and portfolio.
  • Analyst Reports:

    • Consult recent analyst coverage for professional assessments of how Enovix's patents impact their market position.

Disclaimer

Please note that my information is based on data available up to October 2023. There may have been new developments regarding Enovix's patent portfolio after that date. Always refer to the most recent sources for the latest information.

We bought Enovix today ($ENVX on Nasdaq) and here are some reasons why!



Monday, September 2, 2024

QuantumScape Corporation is a pioneering company in the energy storage sector, focusing on the development and commercialization of solid-state lithium-metal batteries!

 


QuantumScape ($QS on Nasdaq) 

QS's next-generation batteries promise to revolutionize the electric vehicle (EV) industry by offering several key advantages over traditional lithium-ion batteries, including higher energy density, faster charging times, enhanced safety, and a more sustainable lifecycle.

Key Investment Highlights:

  1. Innovative Technology: QuantumScape's solid-state batteries use a unique ceramic separator and an anode-free design, which addresses many of the limitations of current lithium-ion technology. These innovations enable higher energy density and faster charging, which are critical for the widespread adoption of electric vehicles.

  2. Strategic Partnerships: The company has a significant partnership with Volkswagen Group's battery subsidiary, PowerCo. This collaboration is focused on scaling up the production of QuantumScape's batteries, with the potential to reach up to 80 GWh per year, which could power approximately one million vehicles annually. This partnership provides QuantumScape with a strong path to commercialization and market penetration​(Metal Tech News).

  3. Strong Financial Position: As of the second quarter of 2024, QuantumScape holds approximately $900 million in cash and cash equivalents. This robust cash position allows the company to continue its extensive research and development efforts, which are crucial as it moves towards commercial production​(QuantumScape).

  4. Milestones and Progress: QuantumScape has made significant progress in its technology development, recently shipping its Alpha-2 prototype cells to automotive customers. These prototypes serve as a bridge to the company's planned QSE-5 cells, which are expected to be commercialized in the near future. The company is on track to begin high-volume production by 2025​(QuantumScape,Electrek).

  5. Market Potential: The global transition to electric vehicles is a massive growth opportunity. As the EV market expands, the demand for better, more efficient battery technology will surge.

  6.  QuantumScape's solid-state batteries are positioned to meet this demand, potentially capturing a significant share of the market.

Investment Risks:

  • Technology and Production Risks: While QuantumScape has made significant strides, transitioning from prototype to mass production of solid-state batteries involves complex challenges, including manufacturing scale-up and quality control. The success of these efforts will be critical to the company's future.

  • Commercialization Timeline: QuantumScape's technology is still in the development phase, with full-scale commercial production expected to begin in 2025. Investors need to consider the potential delays and challenges that could arise during this period.

QuantumScape represents a high-risk, high-reward opportunity, with the potential to become a key player in the future of energy storage and electric vehicles. Investors should weigh the company's innovative technology and strong partnerships against the inherent risks of bringing a new technology to market.

Technology

QuantumScape has recently achieved several significant milestones as it advances toward the commercialization of its solid-state lithium-metal battery technology. The company has started shipping its Alpha-2 prototype cells to automotive customers. These Alpha-2 cells represent a crucial step in QuantumScape's development process, bridging the gap between its earlier prototypes and the upcoming QSE-5 cells, which are expected to be commercially available later this year. These cells have demonstrated improvements in energy and power density, which are critical for their future application in electric vehicles (EVs)​(QuantumScape,Electrek).

Moreover, QuantumScape has entered into a landmark agreement with Volkswagen's battery subsidiary, PowerCo, to scale up the production of these solid-state batteries. This partnership aims to ramp up production to potentially 80 GWh per year, enough to power around one million vehicles annually. This collaboration is expected to accelerate the industrialization and global adoption of QuantumScape's technology, which is considered pivotal in overcoming the limitations of traditional lithium-ion batteries, such as safety concerns and energy density​(Metal Tech News).

Overall, QuantumScape is making significant strides in both technology development and strategic partnerships, positioning itself as a key player in the future of EV battery technology.

Financials:

As of the second quarter of 2024, QuantumScape's financials reflect its ongoing efforts to advance its solid-state battery technology towards commercialization. Here are some key points from their recent financial report:

  1. Revenue: QuantumScape did not report significant revenue for Q2 2024, as the company is still in the pre-commercialization phase of its technology. The primary focus remains on research, development, and prototype production.

  2. Expenses: The company continues to invest heavily in R&D, which constitutes the majority of its expenses. QuantumScape reported R&D expenses of approximately $76 million for the second quarter. This increase is in line with the company's efforts to advance its solid-state battery technology and scale up production capabilities​(QuantumScape).

  3. Net Loss: QuantumScape reported a net loss of around $118 million for Q2 2024, which is typical for a company in this stage of development. This loss is primarily driven by high R&D costs and the lack of revenue from commercial sales​(QuantumScape).

  4. Cash Position: As of the end of the second quarter, QuantumScape had a strong cash position, with approximately $900 million in cash and cash equivalents. This financial cushion is crucial as the company continues to fund its R&D activities and scale up its manufacturing capabilities​(QuantumScape).

  5. Outlook: QuantumScape's financial outlook remains focused on the future commercialization of its solid-state batteries. The company is working towards achieving key milestones in product development and expects to ramp up production by 2025.

This is a company deeply invested in its technology development, with significant resources allocated to R&D and prototype scaling. While it currently operates at a loss, its substantial cash reserves provide a buffer as it works towards commercial viability in late 2024 with it's new QSE 5 cell technology.

We bought Battery manufacturer, Enovix today ($ENVX on Nasdaq) and here some reasons why!